Literature DB >> 18930995

Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.

I E A Hoffman1, B R Lauwerys, F De Keyser, T W J Huizinga, D Isenberg, L Cebecauer, J Dehoorne, R Joos, G Hendrickx, F Houssiau, D Elewaut.   

Abstract

OBJECTIVE: To investigate differences in clinical signs and symptoms, and in antinuclear antibodies (ANA), between patients with juvenile-onset and adult-onset systemic lupus erythematosus (SLE).
METHODS: Clinical and serological data of 56 patients with juvenile-onset SLE were compared with data of 194 patients with adult-onset SLE. ANA were determined by line immunoassay and by indirect immunofluorescence on Crithidia luciliae.
RESULTS: Renal involvement, encephalopathy and haemolytic anaemia were seen, and anti-dsDNA, anti-ribosomal P and antihistone antibodies found, significantly more often in juvenile-onset SLE. Anti-dsDNA antibodies were directly associated, and anti-ribosomal P antibodies inversely associated, with renal involvement in juvenile-onset SLE. In juvenile patients with SLE and anti-dsDNA and without anti-ribosomal P antibodies the odds ratio for glomerulonephritis was 9.00; no patients with anti-ribosomal P but without anti-dsDNA had renal involvement.
CONCLUSION: Patients with juvenile-onset SLE more often have renal involvement and encephalopathy than patients with adult-onset SLE. Anti-ribosomal P, anti-dsDNA and antihistone antibodies are more often found in patients with juvenile-onset SLE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18930995     DOI: 10.1136/ard.2008.094813

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  47 in total

Review 1.  Taxonomy for systemic lupus erythematosus with onset before adulthood.

Authors:  Clovis A Silva; Tadej Avcin; Hermine I Brunner
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-12       Impact factor: 4.794

2.  Juvenile and adult-onset systemic lupus erythematosus: an ethnicity-based comparison.

Authors:  Rui-Xue Leng; Qing-Qing Zhu; Hai-Feng Pan; Jin-Bao Feng; Jin-Hui Tao; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2010-03-28       Impact factor: 2.631

3.  Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?

Authors:  Rina Mina; Hermine I Brunner
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

Review 4.  [Adolescent rheumatism : The same but different].

Authors:  Sabine Adler
Journal:  Z Rheumatol       Date:  2018-10       Impact factor: 1.372

5.  Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus.

Authors:  Cécile Picard; Jean-Christophe Lega; Bruno Ranchin; Pierre Cochat; Natalia Cabrera; Nicole Fabien; Alexandre Belot
Journal:  Pediatr Nephrol       Date:  2017-03-25       Impact factor: 3.714

6.  Juvenile systemic lupus erythematosus: a single-center experience from southern Turkey.

Authors:  Sibel Balci; Rabia Miray Kisla Ekinci; Aysun Karabay Bayazit; Engin Melek; Dilek Dogruel; Derya Ufuk Altintas; Mustafa Yilmaz
Journal:  Clin Rheumatol       Date:  2019-01-16       Impact factor: 2.980

Review 7.  Reviewing the recommendations for lupus in children.

Authors:  Zehra Serap Arıcı; Ezgi Deniz Batu; Seza Ozen
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

8.  Serum IP-10 is useful for identifying renal and overall disease activity in pediatric systemic lupus erythematosus.

Authors:  Chen-Xing Zhang; Li Cai; Kang Shao; Jing Wu; Wei Zhou; Lan-Fang Cao; Tong-Xin Chen
Journal:  Pediatr Nephrol       Date:  2017-12-20       Impact factor: 3.714

Review 9.  Neurologic manifestations of systemic lupus erythematosus in children and adults.

Authors:  Eyal Muscal; Robin L Brey
Journal:  Neurol Clin       Date:  2010-02       Impact factor: 3.806

Review 10.  Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus.

Authors:  Colin Thorbinson; Louise Oni; Eve Smith; Angela Midgley; Michael W Beresford
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.